SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-14-254869
Filing Date
2014-06-30
Accepted
2014-06-30 11:46:15
Documents
10
Period of Report
2014-06-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d750002d8k.htm 8-K 14032
2 EX-99.1 d750002dex991.htm EX-99.1 41884
3 GRAPHIC g750002img001.jpg GRAPHIC 75873
4 GRAPHIC g750002img002.jpg GRAPHIC 181896
5 GRAPHIC g750002img003.jpg GRAPHIC 167163
6 GRAPHIC g750002img004.jpg GRAPHIC 147429
7 GRAPHIC g750002img005.jpg GRAPHIC 429535
8 GRAPHIC g750002img006.jpg GRAPHIC 154052
9 GRAPHIC g750002img007.jpg GRAPHIC 371721
10 GRAPHIC g750002img008.jpg GRAPHIC 75875
  Complete submission text file 0001193125-14-254869.txt   2267474
Mailing Address P.O. BOX 19534 IRVINE CA 92713-9534
Business Address 2525 DUPONT DRIVE IRVINE CA 92612 7142464500
ALLERGAN INC (Filer) CIK: 0000850693 (see all company filings)

IRS No.: 951622442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-10269 | Film No.: 14947899
SIC: 2834 Pharmaceutical Preparations